Safety and efficacy results from the phase 1/2 study of U3-1402, a human epidermal growth factor receptor 3 (HER3)-directed antibody drug conjugate (ADC), in patients with HER3-expressing metastatic breast cancer (MBC)

被引：0

作者：

Krop, Ian ^{[1
]}

Yonemori, Kan ^{[2
]}

Takahashi, Shunji ^{[3
]}

Inoue, Kenichi ^{[4
]}

Nakayama, Takahiro ^{[5
]}

Iwata, Hiroji ^{[6
]}

Toyama, Tatsuya ^{[7
]}

Yamamoto, Yutaka ^{[8
]}

Takahashi, Masato ^{[9
]}

Osaki, Akihiko ^{[10
]}

Saji, Shigehira ^{[11
]}

Sagara, Yasuaki ^{[12
]}

O'Shaughnessy, Joyce ^{[13
]}

Traina, Tiffany ^{[14
]}

Ohwada, Shoichi ^{[15
]}

Qi, Zhenhao ^{[16
]}

Qiu, Yang ^{[16
]}

Onuma, Hiroshi ^{[15
]}

Sharma, Om ^{[16
]}

Mekan, Sabeen ^{[16
]}

Masuda, Norikazu ^{[17
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Natl Canc Ctr, Tokyo, Japan

[3] Canc Inst Hosp Japanese Fdn Canc Res, Tokyo, Japan

[4] Saitama Canc Ctr, Saitama, Japan

[5] Osaka Int Canc Inst, Osaka, Japan

[6] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[7] Nagoya City Univ, Nagoya, Aichi, Japan

[8] Kumamoto Univ Hosp, Kumamoto, Japan

[9] Natl Hosp Org Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan

[10] Saitama Med Univ Int Med Ctr, Hidaka, Japan

[11] Fukushima Med Univ Hosp, Fukushima, Japan

[12] Hakuaikai Social Med Corp Sagara Hosp, Kagoshima, Japan

[13] Bayero Univ, US Oncol, Texas Oncol, Med Ctr, Dallas, TX USA

[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[15] Daiichi Sankyo Co Ltd, Tokyo, Japan

[16] Daiichi Sankyo Co Ltd, Basking Ridge, NJ USA

[17] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan

来源：

CANCER RESEARCH | 2021年 / 81卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PD1-09

引用

页数：1